Invention Grant
US08765690B2 Treatment of cancer with glufosfamide in patients not receiving insulin therapy
有权
在接受胰岛素治疗的患者中，用氟磷酰胺治疗癌症
- Patent Title: Treatment of cancer with glufosfamide in patients not receiving insulin therapy
- Patent Title (中): 在接受胰岛素治疗的患者中，用氟磷酰胺治疗癌症
-
Application No.: US12594802Application Date: 2008-04-07
-
Publication No.: US08765690B2Publication Date: 2014-07-01
- Inventor: Damian Handisides , Stewart Kroll , Jian-Xin Duan , Harold E. Selick
- Applicant: Damian Handisides , Stewart Kroll , Jian-Xin Duan , Harold E. Selick
- Applicant Address: US CA South San Francisco
- Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2008/059578 WO 20080407
- International Announcement: WO2008/124691 WO 20081016
- Main IPC: A61K31/70
- IPC: A61K31/70
Abstract:
The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.
Public/Granted literature
- US20100104549A1 GLUFOSFAMIDE COMBINATION THERAPY Public/Granted day:2010-04-29
Information query
